Xu Jian-hua, Deng Wan-li, Fan Zhong-ze
Putoo Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai.
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2010 Jul;30(7):743-7.
To evaluate the effects and molecular mechanism of action of Changweiqing (CWQ) in reversing multidrug resistance by observing its impacts on nuclear translocation of Y-box binding protein-1 (YB-1), multi-drug resistance gene (MDR1) expression and P-glycoprotein (P-gp) expression in human colon cancer cell line HCT8/V with drug-resistance induced by vincristine.
Cultured HCT8/V cells were exposed to the CWQ-containing rat serum prepared by drug perfusion. YB-1 expressions in cell plasma and nuclei were examined by Western blot; the binding activity of YB-1 to MDR1 gene promoter sequences was detected by electrophoretic mobility shift assay (EMSA); the mRNA transcription levels of MDR1, YB-1 and multi-resistance related protein (MRP) were examined by RT-PCR; the expression of P-gp on cell membrane was determined by flow cytometry. Results Along with the increasing drug's concentration of CWQ-containing serum from 1.25% up to 2.5% and 5%, the expressions of YB-1 decreased in HCT8/V cell nuclear and increased in cytoplasm gradually; the binding activity of YB-1 to MDR1 gene promoter weakened (P < 0.01), MDR1 mRNA expression and fluorescence intensity of P-gp on cell membrane attenuated (P < 0.05 or P < 0.01), while YB-1 and MRP mRNA unchanged (P > 0.05).
CWQ could reverse the drug-resistance of colon cancer cells by influencing nuclear translocation of YB-1 and reducing the expression of MDR1/P-gp.
通过观察肠胃清(CWQ)对长春新碱诱导的人结肠癌耐药细胞系HCT8/V中Y盒结合蛋白-1(YB-1)核转位、多药耐药基因(MDR1)表达及P-糖蛋白(P-gp)表达的影响,评估其逆转多药耐药的作用及分子机制。
将培养的HCT8/V细胞暴露于经药物灌胃制备的含CWQ大鼠血清中。采用蛋白质免疫印迹法检测细胞浆和细胞核中YB-1的表达;采用电泳迁移率变动分析(EMSA)检测YB-1与MDR1基因启动子序列的结合活性;采用逆转录聚合酶链反应(RT-PCR)检测MDR1、YB-1及多药耐药相关蛋白(MRP)的mRNA转录水平;采用流式细胞术检测细胞膜上P-gp的表达。结果 随着含CWQ血清药物浓度从1.25%增至2.5%和5%,HCT8/V细胞核中YB-1表达逐渐降低,细胞浆中YB-1表达逐渐升高;YB-1与MDR1基因启动子的结合活性减弱(P<0.01),MDR1 mRNA表达及细胞膜上P-gp荧光强度减弱(P<0.05或P<0.01),而YB-1和MRP mRNA表达无变化(P>0.05)。
CWQ可通过影响YB-1核转位及降低MDR1/P-gp表达逆转结肠癌细胞的耐药性。